Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (1)
  • 2023 (1)
  • 2021 (1)
  • 2019 (4)
  • 2018 (3)

Subject

  • Arrests/Convictions - Major (1)
  • Diversion Division (1)
  • Pharmaceuticals/Pharmacists/Physicians (1)
  • Prescription Drugs (1)

Drug Name

  • Fentanyl (55)
  • Methamphetamine (52)
  • Cocaine (22)
  • Heroin (18)
  • Marijuana (Cannabis) (11)
  • Synthetic Opioids (7)
  • Benzodiazepines (1)
  • Ecstasy/MDMA (1)
  • Methadone (1)
  • Opioids (1)
  • Oxycodone (10)

Field Division

  • New England (63)
  • Atlanta (50)
  • New York (34)
  • Washington, DC (23)
  • Miami (19)
  • Seattle (15)
  • San Francisco (14)
  • St. Louis (13)
  • Chicago (8)
  • New Jersey (6)
  • Dallas (5)
  • Houston (5)
  • Sede (5)
  • Detroit (1)
  • El Paso (1)
  • Omaha (1)
  • Phoenix (1)
  • San Diego (1)
  • New Orleans (6)
  • Rocky Mountain (4)
Clear All Results
PRESS RELEASE

Former Doctor and Her Wife Sentenced for Fraud and Other Crimes

Diciembre 19, 2024
HUNTSVILLE, Ala. – A former family practice doctor in Huntsville was sentenced today for drug crimes, health care fraud, and COVID-19 disaster relief fraud, announced U.S. Attorney Prim F. Escalona, FBI Special Agent in Charge Carlton Peeples, Drug Enforcement Administration Special Agent in Charge Steven L. Hofer, and Special Agent...
Diciembre 19, 2024
PRESS RELEASE

Former Gadsden Pharmacist and City School Board Member Sentenced for Drug Distribution Conspiracy and Tax Crimes

Noviembre 02, 2023
BIRMINGHAM, Ala. – A former Gadsden-area pharmacist and city school board member was sentenced yesterday for drug distribution conspiracy and tax crimes, announced U.S. Attorney Prim F. Escalona, Federal Bureau of Investigation Special Agent in Charge Carlton L. Peeples, Drug Enforcement Administration Special Agent in Charge Brad L. Byerley, and...
Noviembre 02, 2023
PRESS RELEASE

DEA Issues Warning Over Counterfeit Pills

Mayo 21, 2021
NEW ORLEANS – DEA is alerting all citizens to an increase in drug overdose deaths tied to counterfeit pills containing the powerful synthetic opioid fentanyl. Manufactured by Mexican drug trafficking (DTOs), and marketed as a medication such as oxycodone on the illicit drug market, these pills can be deadly. One...
Mayo 21, 2021
PRESS RELEASE

Denver doctor pleads guilty to illegally prescribing controlled substances

Octubre 07, 2019
DENVER – United States Attorney Jason R. Dunn announced that Dr. Andrew Mark Ho, age 54, of Denver, pled guilty yesterday to illegally dispensing or illegally causing to be dispensed oxycodone, a controlled substance. Ho pled guilty before Chief U.S. District Court Judge Philip B. Brimmer. Judge Brimmer is scheduled...
Octubre 07, 2019
PRESS RELEASE

Large-scale poly drug trafficking organization dismantled in Colorado

Julio 02, 2019
DENVER – In December of 2018, the Longmont Department of Public Safety Special Enforcement Unit began looking into the drug distribution activities of Joshua Ward, who resided in the city of Longmont. Utilizing various law enforcement investigative techniques, Longmont SEU identified numerous subjects in the northern Colorado region who were...
Julio 02, 2019
PRESS RELEASE

Colorado doctor pleads guilty to distributing oxycodone for no legitimate purpose

Junio 26, 2019
DENVER – John Van Wu, 49, of Golden, pleaded guilty today to one count of distributing oxycodone outside the usual course of medical practice and for no legitimate purpose, announced U.S. Attorney Jason Dunn and DEA Denver Division Special Agent in Charge William McDermott. The plea was accepted by U.S...
Junio 26, 2019
PRESS RELEASE

DEA and U.S. Attorney in the Western District of Louisiana announce settlement with drug distributor

Mayo 24, 2019
NEW ORLEANS – Morris & Dickson Company LLC has agreed to pay the United States $22 million in civil penalties to resolve claims that it violated the Controlled Substances Act by failing to report suspicious orders of hydrocodone and oxycodone, announced Drug Enforcement Administration Special Agent in Charge Brad L...
Mayo 24, 2019
PRESS RELEASE

Confederated Salish and Kootenai Tribes' Pharmacy settles claims

Noviembre 20, 2018
MISSOULA, Colo. – The Confederated Salish and Kootenai Tribes’ Pharmacy and the U.S. Attorney’s Office have reached an agreement settling alleged pharmacy violations in which the pharmacy will pay a $95,520 civil penalty and take other steps to ensure compliance with federal law and U.S. Drug Enforcement Administration regulations, U.S...
Noviembre 20, 2018
PRESS RELEASE

Montgomery Nurse Practitioner convicted of unlawfully distributing controlled substances, health care fraud, and conspiracy

Octubre 31, 2018
MONTGOMERY, Ala. – On Monday, Oct. 29, 2018, a federal jury convicted nurse practitioner Lilian Ifeoma Akwuba, 39, of Montgomery, Alabama, on 17 counts of unlawfully distributing controlled substances, 4 counts of health care fraud, 1 count of conspiring to distribute controlled substances, and 1 count of conspiring to commit...
Octubre 31, 2018
PRESS RELEASE

New Orleans-area defendants plead guilty to fraudulent possession and black market distribution of oxycodone

Octubre 22, 2018
NEW ORLEANS – Eight New Orleans-area defendants have pleaded guilty for their participation in a conspiracy to obtain oxycodone through fraud by using fictitious prescriptions. Six of the eight defendants have also pleaded guilty for their roles in a scheme to possess with intent to distribute oxycodone on the black...
Octubre 22, 2018
Showing 1 - 10 of 10 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster